Position history for Candriam S.C.A.'s holdings in REGENERON PHARMACEUTICALS
Candriam S.C.A. holds 186,388 shares of REGN (REGENERON PHARMACEUTICALS), worth $144M as of 2026-Q1. The position was decreased (-9.2% shares). REGN represents 0.7% of Candriam S.C.A.'s portfolio.
Current Value
$144M
Current Shares
186,388
Total Value Change
-$66.9M
Total Shares Change
-14,320
Other major holders of REGN: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 186,388 |
-9.2% |
| $144M |
| 0.7% |
| $766.66 |
0 |
| 2025-Q4 | Increased | 205,332 | +21.1% | $158.5M | 0.8% | $773.94 | 51 |
| 2025-Q3 | Increased | 169,495 | +19.2% | $95.3M | 0.5% | $560.05 | 42 |
| 2025-Q2 | Decreased | 142,208 | -33.8% | $74.7M | 0.4% | $519.56 | 0 |
| 2025-Q1 | Decreased | 214,941 | -17.8% | $136.3M | 0.9% | $634.66 | 0 |
| 2024-Q4 | Increased | 261,498 | +3.5% | $186.3M | 1.1% | $698.71 | 50 |
| 2024-Q3 | Increased | 252,525 | +25.8% | $265.5M | 1.5% | $1,036.94 | 60 |
| 2024-Q2 | Decreased | 200,708 | -7.8% | $210.9M | 1.3% | $1,045.23 | 0 |